BSE · VIVANZA

Vivanza Biosciences Limited

Sector: Healthcare · ISIN: INE984E01035

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#4,650

of 5,004 stocks

🏆 New peak

▲ 361W

Peak #4,650 · 01 Oct 2026

Vivanza Biosciences Limited, a microcap Healthcare business, is growing revenue rapidly, has a widely-held ownership base, with promoters at just 20%, and trades at a moderate earnings multiple. Ownership as of Jun 2026.

Market Cap

6.96 Cr

P/E Ratio

17.40

P/B Ratio

1.60

ROE

9.05%

ROCE

15.72%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	9.29 Cr	6.36 Cr	45.25 Cr	55.36 Cr
Net Profit	14.66 L	-45.08 L	19.54 L	56.29 L
EPS	0.04	0.11	0.05	0.14
Operating Profit	28.85 L	-23.56 L	28.51 L	61.00 L

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

20.02%

Public

79.98%

PUBLIC BREAKDOWN

DII

0.00%

Individuals

73.94%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-Date	Type	Details
24 Mar 2023	Split	Stock Split From Rs.10/- to Rs.1/-
27 May 2015	Other	Reduction of Capital

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs